Suppr超能文献

2019年冠状病毒病大流行对ST段抬高型心肌梗死治疗策略及预后的影响。

The impact of the COVID-19 pandemic on ST-segment elevation myocardial infarction treatment strategy and outcomes.

作者信息

Bychowski Jakub, Michalski Tomasz, Sobiczewski Wojciech, Jaguszewski Miłosz, Gruchała Marcin

机构信息

1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.

出版信息

Front Cardiovasc Med. 2025 Apr 16;12:1522661. doi: 10.3389/fcvm.2025.1522661. eCollection 2025.

Abstract

BACKGROUND

The most reliable care quality indicators for STEMI patients undergoing primary percutaneous coronary intervention (pPCI) include onset-to-door time (OTDT), time from admission to wire crossing and in-hospital mortality.

AIMS

Our study aimed to evaluate the impact of the COVID-19 pandemic on these selected care quality indicators in pre-pandemic and pandemic groups of STEMI patients.

METHODS

This single-centre, retrospective study, enrolled 480 STEMI patients, aged 63.59 ± 12.44 years treated with pPCI across two time frames: pre-pandemic ( = 331) and pandemic ( = 149). The evaluation criteria included OTDT, time from admission to PCI-mediated reperfusion, in-hospital mortality, and predictors of time delays.

RESULTS

Our study revealed a significant increases in OTDT (median 3 h; IQR 1.5-12.0 vs. median 5 h; IQR 2.0-24.0,  = 0.011) and time from admission to wire crossing (median 92 min; IQR 65.0-187.0 vs. median 115.0; IQR 73.0-233.0,  = 0.025), in the COVID-19 pandemic group of STEMI patients, compared to the pre-pandemic subset. We also observed an increase in in-hospital mortality (7.85% vs. 14.09%,  = 0.033) and incidence of cardiogenic shock/cardiac arrest (16.62% vs. 26.85%,  = 0.009). Additionally, the proportion of patients with prolonged OTDT (24.45% vs. 35.71%,  = 0.019) and extended time from admission to PCI-mediated reperfusion (51.96% vs. 65.77%,  = 0.005) increased during the pandemic period.

CONCLUSIONS

The study's results indicated prolonged OTDT and admission-to-wire crossing times, increased in-hospital mortality, and the higher frequency of cardiogenic shock/cardiac arrest during the COVID-19 pandemic. These findings demonstrate the negative impact of the pandemic on treatment times and outcomes for patients diagnosed with STEMI.

摘要

背景

对于接受直接经皮冠状动脉介入治疗(pPCI)的ST段抬高型心肌梗死(STEMI)患者,最可靠的护理质量指标包括发病至入院时间(OTDT)、入院至导丝通过时间和院内死亡率。

目的

我们的研究旨在评估2019冠状病毒病大流行对STEMI患者大流行前和大流行组中这些选定护理质量指标的影响。

方法

这项单中心回顾性研究纳入了480例STEMI患者,年龄为63.59±12.44岁,在两个时间段接受pPCI治疗:大流行前(n = 331)和大流行期间(n = 149)。评估标准包括OTDT、入院至PCI介导的再灌注时间、院内死亡率和时间延迟的预测因素。

结果

我们的研究显示,与大流行前亚组相比,COVID-19大流行组STEMI患者的OTDT(中位数3小时;IQR 1.5 - 12.0 vs.中位数5小时;IQR 2.0 - 24.提示时间延迟的预测因素。

结果

我们的研究显示,与大流行前亚组相比,COVID-19大流行组STEMI患者的OTDT(中位数3小时;IQR 1.5 - 12.0 vs.中位数5小时;IQR 2.0 - 24.0,P = 0.011)和入院至导丝通过时间(中位数92分钟;IQR 65.0 - 187.0 vs.中位数115.0;IQR 73.0 - 233.0,P = 0.025)显著增加。我们还观察到院内死亡率增加(7.85% vs. 14.09%,P = 0.033)和心源性休克/心脏骤停发生率增加(16.62% vs. 26.85%,P = 0.009)。此外,在大流行期间,OTDT延长的患者比例(24.45% vs. 35.71%,P = 0.019)和入院至PCI介导的再灌注时间延长的患者比例(51.96% vs. 65.77%,P = 0.005)增加。

结论

研究结果表明,在2019冠状病毒病大流行期间,OTDT和入院至导丝通过时间延长,院内死亡率增加,心源性休克/心脏骤停频率更高。这些发现证明了大流行对STEMI确诊患者的治疗时间和结局产生了负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07dd/12041087/403c1ff5675f/fcvm-12-1522661-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验